VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by Jane Street Group LLC

Jane Street Group LLC decreased its position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 1.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 19,152 shares of the company’s stock after selling 284 shares during the period. Jane Street Group LLC owned 0.31% of VanEck Pharmaceutical ETF worth $1,652,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in the company. SBI Securities Co. Ltd. purchased a new stake in shares of VanEck Pharmaceutical ETF in the fourth quarter valued at approximately $29,000. JPMorgan Chase & Co. boosted its stake in shares of VanEck Pharmaceutical ETF by 18.6% in the fourth quarter. JPMorgan Chase & Co. now owns 11,316 shares of the company’s stock valued at $976,000 after buying an additional 1,774 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in shares of VanEck Pharmaceutical ETF in the fourth quarter valued at approximately $1,323,000. Jones Financial Companies Lllp boosted its stake in shares of VanEck Pharmaceutical ETF by 1,827.0% in the fourth quarter. Jones Financial Companies Lllp now owns 5,704 shares of the company’s stock valued at $492,000 after buying an additional 5,408 shares in the last quarter. Finally, Commonwealth Equity Services LLC raised its holdings in VanEck Pharmaceutical ETF by 3.6% during the fourth quarter. Commonwealth Equity Services LLC now owns 17,966 shares of the company’s stock worth $1,550,000 after purchasing an additional 631 shares during the last quarter.

VanEck Pharmaceutical ETF Stock Performance

Shares of PPH stock opened at $86.10 on Monday. The stock has a fifty day moving average price of $87.03 and a 200 day moving average price of $88.33. The stock has a market cap of $619.06 million, a PE ratio of 24.60 and a beta of 0.72. VanEck Pharmaceutical ETF has a 1 year low of $77.67 and a 1 year high of $99.51.

VanEck Pharmaceutical ETF Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 4th. Investors of record on Tuesday, April 1st were issued a dividend of $0.5245 per share. The ex-dividend date of this dividend was Tuesday, April 1st. This is a boost from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31. This represents a $2.10 annualized dividend and a yield of 2.44%.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.